Risk of Violating the U.S. Foreign Corrupt Practices Act
First written in FY2016. 9 of 10 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2021: 1 of 6 companies on the "Worse" side.
7 other companies' latest entry also says "Restated".
- FY2024RestatedAnnual report
「Our Group handles many medical devices manufactured by U.S. companies, and with respect to laws and regulations concerning the prevention of bribery, it must pay attention not only to domestic laws but also to foreign laws, including the U.S. Foreign Corrupt Practices Act (FCPA).」
Continues the risk of violating anti-bribery laws and regulations, including the FCPA, associated with handling products manufactured by U.S. companies. - FY2022RestatedAnnual report
「Our Group handles many medical devices manufactured by U.S. companies, and with respect to laws and regulations concerning the prevention of bribery, it must pay attention not only to domestic laws but also to foreign laws, including the U.S. Foreign Corrupt Practices Act (FCPA).」
Continues the risk of violating anti-bribery laws and regulations, including the FCPA, associated with handling products manufactured by U.S. companies. - FY2020RestatedAnnual report
「Our Group handles many medical devices manufactured by U.S. companies, and with respect to laws and regulations concerning the prevention of bribery, it must pay attention not only to domestic laws but also to foreign laws, including the U.S. Foreign Corrupt Practices Act (FCPA).」
Continues to describe the risk of violating anti-bribery laws and regulations, including the FCPA, associated with handling products manufactured by U.S. companies. - FY2019RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Continues the responses involving guidelines, training, and a management framework to the risk of FCPA violations associated with handling products manufactured by U.S. companies. - FY2019-Q3RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Continues to describe the risk of FCPA violations associated with handling products manufactured by U.S. companies and the responses involving guidelines, training, and a management framework. - FY2019-Q2RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Continues to describe the risk of FCPA violations associated with handling products manufactured by U.S. companies and the responses involving guidelines, training, and a management framework. - FY2019-Q1RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Reiterates the risk of FCPA violations associated with handling products manufactured by U.S. companies and the responses involving guidelines, training, and a management framework. - FY2018RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Reiterates the risk of FCPA violations arising from handling products manufactured by U.S. companies and the responses involving guidelines, training, and a management framework. - FY2017RestatedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Reiterates the risk of FCPA violations arising from handling products manufactured by U.S. companies and the responses involving guidelines, training, and a management framework. - FY2016First statedAnnual report
「Our Group has specified appropriate dealings with public institutions in its compliance guidelines and conducts regular training to thoroughly inform employees of the relevant regulations, while establishing a management framework to prevent the provision of bribes. However, if our understanding or interpretation of the regulations is inconsistent with their content, the U.S. manufacturers and our Group could be found to have violated the regulations.」
Against the backdrop of handling many products manufactured by U.S. companies, indicates the possibility of FCPA violations, suspension of transactions, and a decline in confidence.